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Abstract 
Background: To study the effectiveness of 
choronic villous sampling, followed by molecular 
analysis, for prenatal diagnosis of β thalassaemia  
Methods: In this descriptive study 116 high risk 
mothers with 12-16 weeks of pregnancy, underwent 
choronic villous sampling (CVS) for studying  β 
thalassaemia mutations in fetuses. CVS sampling 
was done with a trans-abdominal route, under local 
anaesthesia  and ultrasound guidance. The choronic 
villi extracted  were investigated upon using 
genomic amplification of  β globin gene by 
amplification refectory mutation system (ARMS). 
The couples were informed about the consequences 
and were advised to act accordingly 
Results: Chorionic villous sampling was advised to 
161 and was done in 116 (72.04%) and 41 (25.46%) 
refused to proceed. Age of mothers ranged from 18 to 
35 years. Nine (7.75%) were primrigravida. 
Consanguineous marriage were found in 85.34% 
couples. Majority (86.2%) previously had a child 
affected with β –thalassaemia  major. On polymerase 
chain reaction , out of 116, 30.17% fetuses were 
diagnosed as  beta thalassaemia major, having 
mutation of both alleles of  β globin gene. One case 
(0.86%)  had unidentified mutation. Frame shift 8-9  
was the commonest mutation (42.85%), followed by 
IVS 1-5 (25.71%).  cap+1 mutation was seen in 2.85%. 
Majority (94.3%) of the couples with β thalassaemia 
decided to abort. Spontaneous abortion, after the 
procedure, was found in one case . 
Conclusion:  Ultrasound guided trans-abdominal 
CVS, with molecular assessment , is an effective 
procedure for prenatal diagnosis of  β thalassaemia     
Key Words:  Prenatal Diagnosis,  β  Thalassaemia , 
Chorionic villous sampling, PCR, ARMS. 
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Introduction 
    Thalassaemias are a heterogeneous group of 
disorders in which the production of normal 
haemoglobin is partly or completely suppressed 
because of diminished synthesis of one or more globin 
chains. According to the chain, which is deficient, 
several types like α and β thalassaemias have been 
described.1  Most β- thalassaemias are caused by point 
mutations, while a few deletions are also known. On 
the contrary α thalassaemias are mostly caused by 
large gene deletions.2 β- thalassaemia is the 
commonest autoosmal recessive single gene disorder 
of haemoglobin synthesis . In Pakistan it is the one of 
the most frequent inherited disorder with a carrier rate 
of 5 to 7 %. In Pakistan approximately 5000 
homozygous thalassaemia children  are born every 
year and there are 50,000 patients of β-  thalassaemia 
in the country.3 Many social problems, like preference 
to marry within same ethnic group and 
consanguineous marriages, have contributed to its 
increased incidence. 4,5  
    CVS was first introduced as a rapid means of 
prenatal diagnosis in early pregnancy, in 1980s. 
Hahnemann was the pioneer of collecting CVS 
samples first through endoscope and then ultrasound 
guided. Subsequently ultrasound guided trans-
abdominal sampling became the most widely used 
technique. The main advantage of trans-abdominal 
technique is its utilization from first trimester to term.  
 For prenatal diagnosis, in  first trimester, CVS is 
advantageous over second trimester amniocentesis 
because of  less emotional and physical stress, less 
obvious pregnancy and therefore more privacy. If 
termination of pregnancy is indicated, the 
contemplation of the procedure will be done at a safer 
 time. Religious scholars, in consultation, with medical 
professionals, do not consider  it non ethical.6,7    
 
Methods  
    This descriptive study was carried out in 
Thalassaemia Centre, Pakistan Institute of Medical 
Sciences. Couples were selected for the test after 
checking red cell indices and haemoglobin  
electrophoresis . After appropriate counselling of the 
couple , placental sample was taken under local 
analgesia with suction cannula by trans-abdominal 
approach. The molecular analysis, to detect mutation 
for   β- thalassaemia, was done by amplification 
refractory mutation system (ARMS). The couples were 
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informed about the consequences and were advised to 
act accordingly   
Results 
CVS was advised to 161 couples and 116 underwent 
the procedure. Mothers were  between the age of 18-35 
years. Mean maternal age was 27.4 years. Majority 
(86.21%) had a previously affected child.CVS was 
done at first conception in 40.6%. Consanguineous 
marriage was seen in 84.48%(Table 1).   
Table 1: CVS Sampling in β  Thalassaemia - 
Patients profile 
Characteristic  
Couples consented for CVS: No(%) 
Couples refused for CVS: No(%) 
116(72.04) 
41(25.46%) 
Maternal  age :Range (Mean) 18- 35 years (27.4 years) 
Mean gestational age : Weeks 12.5 
Primigravida:  No(%) 
Mothers in second pregnancy : No(%) 
> 3rd pregnancy: No(%) 
9(7.75) 
20 (17.24) 
87 (75) 
Consanguineous marriages: No(%) 98(84.48) 
1st cousin : No(%) 89(76.72) 
Previously affected child with beta 
thalassaemia major : No (%) 
100(86.21) 
CVS sampling at first pregnancy: 
No(%) 
16 (5.17%) 
 
Table 2: CVS in β  Thalassaemia -  Results 
Entity No(%) 
Beta thalassaemia major 35(30.17) 
Beta thalassaemia minor 55(47.41) 
Normal 25 (12.55) 
Undetected 1 (0.86) 
Table 3: CVS sampling-  Molecular diagnosis in 
fetuses with β-  thalassaemia major (n=35)  
Mutation No(%) 
Fr 8-9 (+G) 15 (42.85) 
IVS 1-5 (G-C) 9(25.71) 
Fr 41-42 ( TTCT) 5 (14.28) 
Cd 15 (G-) 2(5.71) 
Del 619 1 (2.85) 
 Cap +1 (A-C0 1 (2.85) 
Cd 30 (G-C) 1(2.85) 
Cd  5 (-CT) 1 (2.85) 
   Majority of these were  first cousins (Table 1).CVS 
was attempted between the gestational age of 8-24 
weeks. Mean gestational age, at the time of procedure, 
was 12.6 weeks. In normal and fetuses with trait all 
were born alive, except one which underwent 
spontaneous abortion after  the procedure. Majority 
(94.3%) of the couples, with a fetus with β-thlassaemia 
major, opted for a termination of pregnancy.  After 
DNA analysis 35 cases (30.17%) were diagnoses ad β-
thlassaemia major(Table 2).Molecular diagnosis 
revealed Fr 8-9 in 42.85%, followed by IVS 1-5 in 
25.71%. One case revealed cap +1 mutation (Table 3)  
 
Discussion 
        The provision of CVS sampling in first trimester 
of pregnancy makes it more acceptable. It is preferable 
to do CVS  before 120 days (17 weeks) of pregnancy. A 
study from AFIP revealed that almost all prenatal 
diagnosis were done in the first trimester of pregnancy 
and >95% of the women with a fetus having 
thalassaemia major opted for the termination of 
pregnancy.9.In case of homozygous fetus the 
interruption of pregnancy would be physically and 
emotionally  more acceptable than in later stages of 
pregnancy.8 Prenatal diagnosis is feasible and 
acceptable in a Muslim country such as Pakistan. 9,10      
      Over 200 mutations , so far, have been reported in 
β- globin chain synthesis. Out of these 25% have been 
found in heterogeneous  subcontinent Indo – Pak 
population. Most of the children born with β-  
thalassaemia major are found in developing countries. 
In Pakistan there are approximately 50,000  patients of 
β-  thalassaemia major.11,12   In a carrier couple, with an 
autosomal recessive disorder, , there is 25% risk of 
having a fetus with β-  thalassaemia major, 25% 
chances of a normal conception and 50% chance of a 
fetus with β-  thalassaemia minor. Prenatal diagnosis 
can delineate this status, thereby helping in reducing 
the disease burden.13,14  
     Consanguineous marriages, common in Pakistan, 
have compounded the problem. In present study 
consanguinity was observed in 84.48% couples. A 
study from Karachi revealed consanguinity in 59%. It 
can be ascribed to better urban and literate society in 
Karachi. To offer genetic counselling, extended family 
screening and prenatal diagnosis, in a family set up 
with beta thalassaemia, is more appropriate.13,15 
    Screening practices are in vogue, yet in our set up 
most of the couples, having a child with β- 
thalassaemia major, give a history of screening after 
the birth of an affected child. Factors identified for the 
underutilization of CVS sampling, in our set up, 
include lack of awareness, poor access, delay in 
seeking advice, non-affordability and religious bias.16-20 
    Fetal loss and complications associated with the 
procedure are minimal. This needs to be properly 
imparted, as many refuse to utilize the procedure due 
to inadequate or illogical explanation of the procedure. 
But if properly counselled then majority opted for the 
procedure and choose to terminate the pregnancy if 
fetus is suffering from β-thalassaemia major. 
Compared to the accumulated cost of the long term 
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treatment of beta thalassaemia major, cost incurred on 
CVS and laboratory diagnosis of beta thalassaemia 
mutations is negligible.7,17,5 
     The growing number of facilities providing DNA – 
based diagnostic services for haemoglobin disorders 
provide a basis for far broader clinical molecular 
genetic services capable of applying many new 
techniques for the accurate diagnosis of these 
disorders.5 Almost all forms of thalassaemia and 
structural haemoglobin variants can be diagnosed by 
molecular genetic analysis . The main indication for  
the use of molecular methods in thalassaemia 
diagnosis are prenatal diagnosis, diagnosis  of 
thalassaemia in a previously transfused patient, 
detection  of silent thalassaemia alleles, distinction 
between Hb-E/C and Hb-S/D/Lepore, etc, 
prospective diagnosis of thalassaemia intermedia, 
diagnosis of alpha thalassaemia and diagnosis of rare 
forms  of thalassaemia.9  Common β-  thalassaemia 
mutations found in our set up are IVS1-5(G-C), del-619 
bp del, IVS 1-1, Fr 8/9(+G), Fr 41/42 (-CTTT), Cd30, 
Cd15, IVS 11-1, Fr16,Cap+1 and Cd5. Fr8-9 is more 
common in Punjabis and Pathans.21-23Results of present 
study for spectrum of beta thalassaemia mutations are 
in agreement with  other studies across the country, 
which shows predominance of Fr8-9 and IVS1-5 
mutations in Punjabis and Pathans and Cap +1 as the 
common silent mutation.3,8,24,25 Identical results have 
been observed for Indian population.26 In contrast, 
Mediterranean region studies revealed IVS1-1 (G-A), 
IVS 1-110 (G-A), IVS1-6 (T-C) as predominant beta 
thalassaemia mutations and -101 (C-T) mutations as 
one of the prevalent silent beta thalassaemia 
mutation.27    
    CVS sampling is an invasive procedure. Feasibility 
of a non-invasive approach, alternative to CVS, i.e.,  
enrichment of fetal zeta globin containing nucleated 
red blood cells from maternal blood is not yet 
established. 28-30  
Conclusion 
1.Prenatal diagnosis of β- thalassaemia with 
ultrasound guided CVS sampling , along with 
molecular assessment can prove to be an effective tool 
in preventive strategy of β- thalassaemia 
2.It is required to address the issue of cultural hurdles 
in the   prenatal diagnosis 
3.Effective public awareness , mass level or extended 
family  screening  , premarital screening, genetic 
counseling  and prenatal diagnosis formulate the 
components of an    effective thalassaemia prevention 
programme  
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